Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,522 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical features of antinuclear antibodies-negative type 1 autoimmune hepatitis.
Miyake Y, Iwasaki Y, Kobashi H, Yasunaka T, Ikeda F, Takaki A, Okamoto R, Takaguchi K, Ikeda H, Makino Y, Ando M, Sakaguchi K, Yamamoto K. Miyake Y, et al. Among authors: ikeda f, ikeda h. Hepatol Res. 2009 Mar;39(3):241-6. doi: 10.1111/j.1872-034X.2008.00454.x. Epub 2008 Nov 26. Hepatol Res. 2009. PMID: 19054143
Clinical features of type 1 autoimmune hepatitis in adolescence and early adulthood.
Miyake Y, Iwasaki Y, Kobashi H, Yasunaka T, Ikeda F, Takaki A, Okamoto R, Takaguchi K, Ikeda H, Makino Y, Sakaguchi K, Ando M, Yamamoto K. Miyake Y, et al. Among authors: ikeda f, ikeda h. Hepatol Res. 2009 Aug;39(8):766-71. doi: 10.1111/j.1872-034X.2009.00510.x. Epub 2009 Apr 3. Hepatol Res. 2009. PMID: 19473431
A prospective and comparative cohort study on efficacy and drug resistance during long-term lamivudine treatment for various stages of chronic hepatitis B and cirrhosis.
Nishida T, Kobashi H, Fujioka S, Fujio K, Takaguchi K, Ikeda H, Kawaguchi M, Ando M, Araki Y, Higashi T, Shoji B, Takaki A, Iwasaki Y, Sakaguchi K, Shiratori Y, Yamamoto K. Nishida T, et al. Among authors: ikeda h. J Gastroenterol Hepatol. 2008 May;23(5):794-803. doi: 10.1111/j.1440-1746.2007.05240.x. Epub 2007 Dec 14. J Gastroenterol Hepatol. 2008. PMID: 18086120 Clinical Trial.
Lamivudine treatment improves the prognosis of fulminant hepatitis B.
Miyake Y, Iwasaki Y, Takaki A, Fujioka S, Takaguchi K, Ikeda H, Kobashi H, Sakaguchi K, Shiratori Y. Miyake Y, et al. Among authors: ikeda h. Intern Med. 2008;47(14):1293-9. doi: 10.2169/internalmedicine.47.1061. Epub 2008 Jul 15. Intern Med. 2008. PMID: 18628576 Free article.
Factors associated with adherence to combination therapy of interferon and ribavirin for patients with chronic hepatitis C: importance of patient's motivation and physician's treatment experience.
Tanioka D, Iwasaki Y, Araki Y, Osawa T, Ikeda H, Ando M, Kobashi H, Sakaguchi K, Shiratori Y, Yamamoto K. Tanioka D, et al. Among authors: ikeda h. Liver Int. 2009 May;29(5):721-9. doi: 10.1111/j.1478-3231.2008.01964.x. Epub 2009 Jan 6. Liver Int. 2009. PMID: 19141025 Clinical Trial.
Efficacy of ursodeoxycholic acid for Japanese patients with autoimmune hepatitis.
Miyake Y, Iwasaki Y, Kobashi H, Yasunaka T, Ikeda F, Takaki A, Okamoto R, Takaguchi K, Ikeda H, Makino Y, Ando M, Sakaguchi K, Yamamoto K. Miyake Y, et al. Among authors: ikeda f, ikeda h. Hepatol Int. 2009 Dec;3(4):556-62. doi: 10.1007/s12072-009-9155-9. Epub 2009 Oct 22. Hepatol Int. 2009. PMID: 19847577 Free PMC article.
4,522 results